|
1
|
Glebov K, Löchner M, Jabs R, Lau T, Merkel
O, Schloss P, Steinhäuser C and Walter J: Serotonin stimulates
secretion of exosomes from microglia cells. Glia. 63:626–634. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang Y, Gao H, Zhang W, Zhang W and Fang
L: Thymoquinone inhibits lipopolysaccharide-induced inflammatory
mediators in BV2 microglial cells. Int Immunopharmacol. 26:169–173.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim M, Choi SY, Lee P and Hur J:
Neochlorogenic acid inhibits lipopolysaccharide-induced activation
and pro-inflammatory responses in BV2 microglial cells. Neurochem
Res. 40:1792–1798. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chun E, Lavoie S, Michaud M, Gallini CA,
Kim J, Soucy G, Odze R, Glickman JN and Garrett WS: CCL2 promotes
colorectal carcinogenesis by enhancing polymorphonuclear
myeloid-derived suppressor cell population and function. Cell Rep.
12:244–257. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsaur I, Rutz J, Makarević J, Juengel E,
Gust KM, Borgmann H, Schilling D, Nelson K, Haferkamp A, Bartsch G
and Blaheta RA: CCL2 promotes integrin-mediated adhesion of
prostate cancer cells in vitro. World J Urol. 33:1051–1056. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mbefo MK, Fares MB, Paleologou K, Oueslati
A, Yin G, Tenreiro S, Pinto M, Outeiro T, Zweckstetter M, Masliah E
and Lashuel H: Parkinson disease mutant E46 K enhances α-synuclein
phosphorylation in mammalian cell lines, in yeast and in vivo. J
Biol Chem. 290:9412–9427. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moree B, Yin G, Lázaro DF, Munari F,
Strohäker T, Giller K, Becker S, Outeiro TF, Zweckstetter M and
Salafsky J: Small molecules detected by second-harmonic generation
modulate the conformation of monomeric α-synuclein and reduce its
aggregation in cells. J Biol Chem. 290:27582–27593. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kempuraj D, Thangavel R, Yang E, Pattani
S, Zaheer S, Santillan DA, Santillan MK and Zaheer A: Dopaminergic
Toxin 1-Methyl-4-Phenylpyridinium, proteins α-synuclein and glia
maturation factor activate mast cells and release inflammatory
mediators. PLoS One. 10:e01357762015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shinozaki Y, Shibata K, Yoshida K,
Shigetomi E, Gachet C, Ikenaka K, Tanaka KF and Koizumi S:
Transformation of Astrocytes to a neuroprotective phenotype by
microglia via P2Y1 receptor downregulation. Cell Rep. 19:1151–1164.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mangino G, Famiglietti M, Capone C, Veroni
C, Percario ZA, Leone S, Fiorucci G, Lülf S, Romeo G, Agresti C, et
al: HIV-1 myristoylated Nef treatment of murine microglial cells
activates inducible nitric oxide synthase, NO2 production and
neurotoxic activity. PLoS One. 10:e01301892015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cox DJ, Field RH, Williams DG, Baran M,
Bowie AG, Cunningham C and Dunne A: DNA sensors are expressed in
astrocytes and microglia in vitro and are upregulated during
gliosis in neurodegenerative disease. Glia. 63:812–825. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Van der Perren A, Macchi F, Toelen J,
Carlon MS, Maris M, de Loor H, Kuypers DR, Gijsbers R, van den
Haute C, Debyser Z and Baekelandt V: FK506 reduces
neuroinflammation and dopaminergic neurodegeneration in an
α-synuclein-based rat model for Parkinson's disease. Neurobiol
Aging. 36:1559–1568. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang Y and Le W: Differential roles of M1
and M2 microglia in neurodegenerative diseases. Mol Neurobiol.
53:1181–1194. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harms AS, Cao S, Rowse AL, Thome AD, Li X,
Mangieri LR, Cron RQ, Shacka JJ, Raman C and Standaert DG: MHCII is
required for α-synuclein-induced activation of microglia, CD4 T
cell proliferation and dopaminergic neurodegeneration. J Neurosci.
33:9592–9600. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Daher JP, Volpicelli-Daley LA, Blackburn
JP, Moehle MS and West AB: Abrogation of α-synuclein-mediated
dopaminergic neurodegeneration in LRRK2-deficient rats. Proc Natl
Acad Sci USA. 111:9289–9294. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Codolo G, Plotegher N, Pozzobon T, Brucale
M, Tessari I, Bubacco L and de Bernard M: Triggering of
inflammasome by aggregated α-synuclein, an inflammatory response in
synucleinopathies. PLoS One. 8:e553752013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim RY, Hoffman AS, Itoh N, Ao Y, Spence
R, Sofroniew MV and Voskuhl RR: Astrocyte CCL2 sustains immune cell
infiltration in chronic experimental autoimmune encephalomyelitis.
J Neuroimmunol. 274:53–61. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kempuraj D, Thangavel R, Fattal R, Pattani
S, Yang E, Zaheer S, Santillan DA, Santillan MK and Zaheer A: Mast
cells release chemokine CCL2 in response to parkinsonian toxin
1-Methyl-4-Phenyl-Pyridinium (MPP+). Neurochem Res. 41:1042–1049.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bose S and Cho J: Role of chemokine CCL2
and its receptor CCR2 in neurodegenerative diseases. Arch Pharm
Res. 36:1039–1050. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gómez-Nicola D, Schetters ST and Perry VH:
Differential role of CCR2 in the dynamics of microglia and
perivascular macrophages during prion disease. Glia. 62:1041–1052.
2014. View Article : Google Scholar : PubMed/NCBI
|
